Michael Rudolph to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Michael Rudolph has written about Xenograft Model Antitumor Assays.
Connection Strength
0.040
-
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clin Cancer Res. 2020 06 15; 26(12):3058-3070.
Score: 0.040
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.